Gastroenterology Section, Department of Medicine, Temple University School of Medicine, Philadelphia, PA, USA.
Internal Medicine, Department of Medicine, Temple University School of Medicine, Philadelphia, PA, USA.
Clin Mol Hepatol. 2019 Dec;25(4):374-380. doi: 10.3350/cmh.2019.0019. Epub 2019 Jul 18.
There is a lack of data on long-term morbidity, particularly dysphagia, following endoscopic variceal band ligation (EVL). The aim of this study are to assess the incidence of dysphagia and variables associated with this complication after EVL.
We identified individuals who completed at least one session of EVL as their sole treatment for varices from August 2012 to December 2017. Included patients achieved "complete eradication" of varices not requiring further therapy. Patients ≥90 days from their last EVL session completed a modified version of the Mayo Clinic Dysphagia Questionnaire. Individuals with dysphagia were invited to undergo a barium esophagram. Patients with pre-EVL dysphagia were excluded.
Of the patients, 68 possessed inclusion criteria, nine (13.2%) died and 20 (29.4%) were lost to follow up. For the remaining 39 (57.4%) patients, 23 were males, mean age of 61.7±8.6 years. The most common etiology of liver disease was hepatitis C virus (n=18; 46.2%). The median number of banding sessions was 2.0 (interquartile range [IQR], 1.0-4.0) with a median of 9.0 bands placed (IQR, 3.0-14.0). Twelve patients (30.8%) developed new-onset dysphagia post-EVL. In univariate analysis, pre-EVL MELD score and non-emergent initial banding were associated with long-term dysphagia. In a regression model adjusted for age, sex, number of bands, and use of acid suppression after EVL, no factor was independently associated with dysphagia (all P>0.05). No strictures were identified on subsequent esophageal evaluation.
Approximately 30% of patients developed new-onset, chronic dysphagia post-EVL. Incident dysphagia was associated with a non-emergent initial banding session. The mechanism for dysphagia remains unknown.
内镜下食管静脉曲张套扎术(EVL)后长期发病率的数据,特别是吞咽困难的数据较为缺乏。本研究旨在评估 EVL 后吞咽困难的发生率及与该并发症相关的变量。
我们从 2012 年 8 月至 2017 年 12 月期间,确定了至少完成一次 EVL 作为静脉曲张唯一治疗的个体。纳入的患者均达到了无需进一步治疗即可“完全消除”静脉曲张的标准。在最后一次 EVL 治疗后≥90 天的患者完成改良版 Mayo 诊所吞咽困难问卷。有吞咽困难的患者接受钡餐食管造影。排除有 EVL 前吞咽困难的患者。
符合纳入标准的患者有 68 例,其中 9 例(13.2%)死亡,20 例(29.4%)失访。在剩余的 39 例(57.4%)患者中,男性 23 例,平均年龄 61.7±8.6 岁。最常见的肝病病因是丙型肝炎病毒(n=18;46.2%)。套扎治疗的中位次数为 2.0 次(四分位距 [IQR],1.0-4.0),中位使用套扎环 9.0 个(IQR,3.0-14.0)。12 例(30.8%)患者在 EVL 后出现新发吞咽困难。单因素分析显示,EVL 前 MELD 评分和非紧急初始套扎与长期吞咽困难相关。在调整年龄、性别、套扎环数量以及 EVL 后使用抑酸治疗的回归模型中,没有一个因素与吞咽困难独立相关(均 P>0.05)。随后的食管评估均未发现狭窄。
大约 30%的 EVL 后患者出现新发、慢性吞咽困难。新发吞咽困难与非紧急初始套扎治疗有关。吞咽困难的发生机制尚不清楚。